Komori
Governance4889Renascience Inc.Pharmaceuticals

Independent Officer Notification Form

An Independent Officers Notification Form was filed because a proposal to elect outside officers will be submitted to the annual general meeting. 3 outside directors have been reported as independent officers.

Worth reading
—
Scored from 0 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
3
people (independent officers)
Wording
Definitive
How definitive the wording is.

Governance structure

Number of directors3 outside directors (total number of directors: Not disclosed)
Number of independent officers3Number

This is the number of people reported to the exchange as independent officers. Whether someone is an outside officer and whether they qualify as independent are separate determinations.

Changes this time

An Independent Officers Notification Form was filed because a proposal to elect outside officers will be submitted to the annual general meeting. 3 outside directors have been reported as independent officers.

Governance structure
ItemDetails
Number of directors3 outside directors (total number of directors: Not disclosed)
Number of independent officers3
Changes this timeAn Independent Officers Notification Form was filed because a proposal to elect outside officers will be submitted to the annual general meeting. 3 outside directors have been reported as independent officers.
Items this document does not state (5)
Corporate Governance StructureCommitteePolicy on cross-shareholdingsTakeover defensesControlling shareholder

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Because a proposal to elect outside officers will be submitted to the annual general meeting. Each candidate has been designated as an independent officer because they have no special interest in the company and are not at risk of having a conflict of interest with general shareholders.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Independent Officer Notification Form | Renascience Inc. (4889) timely disclosure | Komori